Clinical Trials Logo

Pulmonary Precancerous Condition clinical trials

View clinical trials related to Pulmonary Precancerous Condition.

Filter by:
  • Terminated  
  • Page 1

NCT ID: NCT01013831 Terminated - Dysplasia Clinical Trials

Erlotinib Hydrochloride in Preventing Cancer in Patients With Precancerous Lesions of the Lung

Start date: October 2009
Phase: Phase 1
Study type: Interventional

This phase I trial studies the side effects and best dose of erlotinib hydrochloride in preventing cancer in patients with precancerous lesions of the lung. Erlotinib hydrochloride may stop the growth of tumor cells by blocking some of the enzymes needed for cell growth.